AU2001234655A1 - Methods for determining risk of developing cervical cancer - Google Patents

Methods for determining risk of developing cervical cancer

Info

Publication number
AU2001234655A1
AU2001234655A1 AU2001234655A AU3465501A AU2001234655A1 AU 2001234655 A1 AU2001234655 A1 AU 2001234655A1 AU 2001234655 A AU2001234655 A AU 2001234655A AU 3465501 A AU3465501 A AU 3465501A AU 2001234655 A1 AU2001234655 A1 AU 2001234655A1
Authority
AU
Australia
Prior art keywords
methods
cervical cancer
determining risk
developing cervical
developing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001234655A
Inventor
Rajesh S. Mathur
Subbi P. Mathur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical University of South Carolina Foundation
Original Assignee
Medical University of South Carolina Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical University of South Carolina Foundation filed Critical Medical University of South Carolina Foundation
Publication of AU2001234655A1 publication Critical patent/AU2001234655A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001234655A 2000-01-28 2001-01-29 Methods for determining risk of developing cervical cancer Abandoned AU2001234655A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17899500P 2000-01-28 2000-01-28
US60178995 2000-01-28
PCT/US2001/003009 WO2001054713A1 (en) 2000-01-28 2001-01-29 Methods for determining risk of developing cervical cancer

Publications (1)

Publication Number Publication Date
AU2001234655A1 true AU2001234655A1 (en) 2001-08-07

Family

ID=22654788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001234655A Abandoned AU2001234655A1 (en) 2000-01-28 2001-01-29 Methods for determining risk of developing cervical cancer

Country Status (5)

Country Link
US (2) US6890514B2 (en)
EP (1) EP1253934A4 (en)
AU (1) AU2001234655A1 (en)
CA (1) CA2398477C (en)
WO (1) WO2001054713A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT5228B (en) 2003-07-16 2005-06-27 Uždaroji akcinė bendrovė Melofarma Methos of early diagnosis in vitro of cervix uteri dysplasia and cancer related to human papilloma viruses
CN1922490B (en) 2004-02-19 2012-07-04 耶鲁大学 Identification of cancer protein biomarkers using proteomic techniques
US9942511B2 (en) 2005-10-31 2018-04-10 Invention Science Fund I, Llc Preservation/degradation of video/audio aspects of a data stream
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
WO2010129821A1 (en) 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512657A (en) 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
EP0531080A3 (en) 1991-09-04 1993-12-29 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
AU7713498A (en) 1997-06-03 1998-12-21 Amdl, Inc. Immunoassay for the detection of cancer
US6063586A (en) * 1997-09-03 2000-05-16 Eye & Ear Foundation Diagnostic protocol

Also Published As

Publication number Publication date
US20030017505A1 (en) 2003-01-23
US20050037342A1 (en) 2005-02-17
CA2398477A1 (en) 2001-08-02
EP1253934A4 (en) 2005-01-05
US6890514B2 (en) 2005-05-10
WO2001054713A1 (en) 2001-08-02
CA2398477C (en) 2006-01-24
EP1253934A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AU2002360766A1 (en) Methods for cancer imaging
AU2002309811A1 (en) System for creating blueprints from measurements
EP1291726A3 (en) Toner and heat-fixing method
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2001268069A1 (en) Apparatus for the display of embedded information
AU2002312182A1 (en) Sub-resolution alignment of images
AU2001251348A1 (en) Apparatus for sensing human prostate tumor
AU2001282504A1 (en) System for measuring the correct size of shoes
AU2001255602A1 (en) Methods for treating bone tumors
AU2002340139A1 (en) Inhibitors of the egf receptor for the treatment of thyroid cancer
AUPQ958400A0 (en) Validation of transactions
AU2002216080A1 (en) Method for determining competing risks
AU2001288090A1 (en) System for evaluating profitability of developed medicine
AU2001234655A1 (en) Methods for determining risk of developing cervical cancer
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU2001288921A1 (en) Human breast cancer biomarkers
AU2001270908A1 (en) Methods for detection of human papillomavirus mrna
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001246862A1 (en) Method of detecting cancer
AU2002366255A1 (en) An aid for dressing
AU2002222484A1 (en) Photolithographic method including measurement of the latent image
AU2002309668A1 (en) Methods for determining the prognosis for cancer patients using tucan
AU2001229209A1 (en) Hydrokeratome for refractive surgery
AU2001244025A1 (en) Method for predicting the results of cosmetic surgery
AU2002341079A1 (en) Method of reducing the size of an rsa or rabin signature